
Avadel Shareholders Approve Acquisition by Alkermes

I'm PortAI, I can summarize articles.
Avadel Pharmaceuticals shareholders have approved the acquisition by Alkermes plc, with 97.41% voting in favor. The resolutions related to the transaction received strong support at the scheme meeting. Additionally, shareholders approved the compensatory arrangements for the company’s named executive officers in connection with the acquisition.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

